生物
重编程
癌变
细胞命运测定
肝细胞
细胞生物学
转录因子
肝细胞核因子
癌症研究
抑制因子
转分化
遗传学
细胞
癌症
干细胞
基因
体外
作者
Bryce Lim,Aryan Kamal,Borja Gomez Ramos,Juan M. Adrian-Segarra,Ignacio L. Ibarra,Lennart Dignas,Tim Kindinger,Kai Volz,Mohammad Rahbari,Nuh N. Rahbari,Eric Poisel,Kanela Kafetzopoulou,Lio Böse,Marco Breinig,Danijela Heide,Suchira Gallage,Jose Efren Barragan Avila,Hendrik Wiethoff,Ivan Berest,Sarah Schnabellehner
标识
DOI:10.1038/s41588-025-02081-w
摘要
Abstract Cell fate plasticity enables development, yet unlocked plasticity is a cancer hallmark. While transcription master regulators induce lineage-specific genes to restrict plasticity, it remains unclear whether plasticity is actively suppressed by lineage-specific repressors. Here we computationally predict so-called safeguard repressors for 18 cell types that block phenotypic plasticity lifelong. We validated hepatocyte-specific candidates using reprogramming, revealing that prospero homeobox protein 1 (PROX1) enhanced hepatocyte identity by direct repression of alternative fate master regulators. In mice, Prox1 was required for efficient hepatocyte regeneration after injury and was sufficient to prevent liver tumorigenesis. In line with patient data, Prox1 depletion caused hepatocyte fate loss in vivo and enabled the transition of hepatocellular carcinoma to cholangiocarcinoma. Conversely, overexpression promoted cholangiocarcinoma to hepatocellular carcinoma transdifferentiation. Our findings provide evidence for PROX1 as a hepatocyte-specific safeguard and support a model where cell-type-specific repressors actively suppress plasticity throughout life to safeguard lineage identity and thus prevent disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI